Finance

Beta
Lists
MDT:NYSE
Medtronic PLC
$80.13
-0.62%
(-0.50) 1D
$80.78
+0.81% (+0.65)
After hours
Closed: Jun 24, 4:00:06 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MDT...
Open
$80.12
High
$82.09
Low
$80.07
Mkt. cap
102.57B
Avg. vol.
11.50M
Volume
8.82M
Dividend
3.59%
Quarterly dividend
$0.72
Ex-dividend date
Jun 26, 2026
P/E ratio
21.50
52-wk high
$106.33
52-wk low
$73.31
EPS
$3.73
Beta
0.58
Shares outstanding
1.28B
No. of employees
95K
Open
$80.12
High
$82.09
Low
$80.07
Mkt. cap
102.57B
Avg. vol.
11.50M
Volume
8.82M
Dividend
3.59%
Quarterly dividend
$0.72
Ex-dividend date
Jun 26, 2026
P/E ratio
21.50
52-wk high
$106.33
52-wk low
$73.31
EPS
$3.73
Beta
0.58
Shares outstanding
1.28B
No. of employees
95K
News stories
From sources across the web
Profile
Medtronic plc is an American-Irish medical device company. The company's legal and executive headquarters are in Ireland, while its operational headquarters are in Minneapolis, Minnesota. Medtronic rebased to Ireland following its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United States, it operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. It is one of the biggest medical tech companies in the world and is currently the largest medical device company in the world by revenue. The company has developed several world-first technologies since its inception, including wearable and implantable pacemakers, the implantable cardioverter-defibrillator, and remote patient monitoring systems. They also created miniaturized devices like the world's smallest pacemaker and spinal cord stimulator. Wikipedia
About Medtronic PLC
CEOGeoffrey S. Martha
Employees95K
Founded1949
Headquarters-
SectorMedical device
Websitemedtronic.com
Analyst Ratings
Based on 21 analysts giving stock ratings to MDT in the past 3 months
Buy
Buy
13
Hold
8
Sell
0
12 month forecast
Based on 21 Wall Street analysts offering 12 month price targets for MDT in the last 3 months.
Highest
Current $80.13
$120.00 (+49.76%)
Average
$97.90 (+22.18%)
Lowest
$80.00 (-0.16%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Ryan Zimmerman
BTIG
Buy
Maintained
$90.00
+12.3%
06/22/2026
Michael Matson
Needham
Buy
Reiterated
$101.00
+26%
06/17/2026
Matthew O'Brien
Piper Sandler
Hold
Reiterated
$85.00
+6.1%
06/17/2026
Larry Biegelsen
Wells Fargo
Buy
Maintained
$102.00
+27.3%
06/15/2026
Travis Steed
Bank of America Securities
Buy
Reiterated
$95.00
+18.6%
06/12/2026
Robbie Marcus
J.P. Morgan
Hold
Maintained
$86.00
+7.3%
06/05/2026
David Roman
Goldman Sachs
Hold
Maintained
$83.00
+3.6%
06/04/2026
Lee Hambright
Bernstein
Buy
Maintained
$97.00
+21.1%
06/04/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
$106.00
+32.3%
06/04/2026
Richard Newitter
Truist Financial
Hold
Reiterated
$86.00
+7.3%
06/04/2026
Shagun Singh Chadha
RBC Capital
Buy
Reiterated
$118.00
+47.3%
06/03/2026
David Rescott
Robert W. Baird
Hold
Maintained
$85.00
+6.1%
06/04/2026
Josh Jennings
TD Cowen
Buy
Reiterated
$119.00
+48.5%
06/04/2026
Joanne Wuensch
Citi
Buy
Maintained
$110.00
+37.3%
06/03/2026
Priya Sachdeva
UBS
Hold
Reiterated
$85.00
+6.1%
06/04/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
06/03/2026
Rick Wise
Stifel Nicolaus
Hold
Maintained
$80.00
-0.2%
06/03/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
$100.00
+24.8%
06/03/2026
Matthew Taylor
Jefferies
Hold
Reiterated
$95.00
+18.6%
04/24/2026
David Toung
Argus Research
Buy
Maintained
$115.00
+43.5%
04/06/2026
Matt Miksic
Barclays
Buy
Maintained
$120.00
+49.8%
04/01/2026
Nico Chen
DBS
Hold
Maintained
$90.00
+12.3%
03/18/2026
Unknown Analyst
CICC
Buy
Initiated
$121.00
+51%
01/30/2026
Last report
Jun 3, 2026
Fiscal period
Q4 2026
EPS / Est. (USD)
$1.55 / $1.54
+0.56%beat
Revenue / Est. (USD)
9.81B / 9.61B
+2.02%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
8.58B
8.96B
9.02B
9.81B
Cost of goods sold
2.98B
3.06B
3.17B
3.40B
Cost of revenue
2.98B
3.06B
3.17B
3.40B
Research and development expenses
726.00M
754.00M
722.00M
671.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.78B
2.94B
2.93B
3.04B
Operating expense
3.99B
4.08B
4.04B
4.25B
Total operating expenses
6.98B
7.14B
7.21B
7.64B
Operating income
1.60B
1.82B
1.80B
2.16B
Other non operating income
68.00M
3.00M
13.00M
154.00M
EBT including unusual items
1.30B
1.60B
1.40B
1.84B
EBT excluding unusual items
1.62B
1.68B
1.66B
2.16B
Income tax expense
255.00M
215.00M
254.00M
575.00M
Effective tax rate
19.59%
13.47%
18.10%
31.34%
Other operating expenses
72.00M
-29.00M
-79.00M
126.00M
Net income
1.04B
1.37B
1.14B
1.24B
Net profit margin
12.12%
15.33%
12.68%
12.68%
Earnings per share
1.26
1.36
1.36
1.55
Interest and investment income
120.00M
89.00M
102.00M
73.00M
Interest expense
-176.00M
-181.00M
-181.00M
-176.00M
Net interest expenses
-56.00M
-92.00M
-79.00M
-103.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.31B
2.52B
2.52B
2.88B
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer